Dig­i­tal tech boost­ed Pfiz­er com­mer­cial, R&D gains dur­ing Covid — and there’s no go­ing back, ex­ecs say

Pfiz­er went dig­i­tal in a big way dur­ing the Covid pan­dem­ic — and it’s not go­ing back, ex­ec­u­tives said at Cowen’s an­nu­al health­care con­fer­ence on Mon­day.

From clin­i­cal tri­als that used pre­dic­tive mod­el­ing to pin­point Covid surges to the use of ar­ti­fi­cial in­tel­li­gence to mon­i­tor Cormi­nar­ty vac­cine freez­er stor­age to com­ple­men­tary dig­i­tal sales rep mod­els, Pfiz­er adopt­ed an ac­cel­er­at­ed raft of tech­nolo­gies that the Big Phar­ma plans to keep.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER